Cognoptixsapphireii stockphoto3
Screen 20shot 202020 05 06 20at 207.20.24 20pm

Cognoptix

Medical device/diagnostic for the early stage detection of Alzheimer's. In office simple ocular lens scan, non-invasive, safe, lower cost (1/20 of cost of PET).

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Marlborough, MA, USA
  • Currency USD
  • Founded January 2012
  • Employees 4
  • Incorporation Type C-corp
  • Website cognoptix.com

Company Summary

Cognoptix is a medical device/diagnostic company for the early stage detection of Alzheimer's. In office simple ocular lens scan, non-invasive, safe, lower cost (1/20 of cost of PET). We are commercial ready to fulfill a profound medical need for early AD identification. New experienced management, new world-class SAB, fast moving program ahead of milestones. >$1B market, high ROI opportunity. Cognoptix is superior to the leading blood diagnostic

Advisors

  • Default avatar
    Lee E. Goldstein, MD, PhD - Scientific Chair, Co-Founder
    Unconfirmed
    Default avatar
    Philip Scheltens, MD, PhD
    Unconfirmed
    Default avatar
    Marwan N. Sabbagh, MD
    Unconfirmed